Curaleaf Holdings Files 6-K, Incorporates Exhibit 99.1

Ticker: CURLF · Form: 6-K · Filed: 2025-08-07T00:00:00.000Z

Sentiment: neutral

Topics: registration-statement, corporate-update, filing

TL;DR

Curaleaf filed a 6-K, incorporating an exhibit into its F-10. Standard update.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on August 7, 2025, for the period ending June 30, 2025. The filing incorporates by reference Exhibit 99.1 into its Form F-10 registration statement. The company is incorporated in Canada and previously operated under the name Lead Ventures Inc. before changing its name on October 23, 2018.

Why It Matters

This filing updates the company's registration statement, which is crucial for ongoing compliance and potential future capital raises.

Risk Assessment

Risk Level: low — This is a routine filing that incorporates previously submitted information into a registration statement.

Key Players & Entities

FAQ

What is the purpose of incorporating Exhibit 99.1 into the Form F-10 registration statement?

Exhibit 99.1 is incorporated by reference into the Company's Registration Statement on Form F-10 (File No. 333-269109) to update or supplement the information contained therein.

What is the reporting period for this Form 6-K filing?

The conformed period of report for this filing is June 30, 2025.

When was Curaleaf Holdings, Inc. previously known as?

The company was formerly known as Lead Ventures Inc.

On what date did the company change its name from Lead Ventures Inc.?

The date of the name change was October 23, 2018.

What is the SEC file number for the Form F-10 registration statement mentioned in the filing?

The SEC file number for the Form F-10 registration statement is 333-269109.

From the Filing

0001756770-25-000030.txt : 20250807 0001756770-25-000030.hdr.sgml : 20250807 20250806204338 ACCESSION NUMBER: 0001756770-25-000030 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250807 DATE AS OF CHANGE: 20250806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 251191232 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 q2256-kcover.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ INCORPORATION BY REFERENCE Exhibit 99.1 to this Form 6-K of Curaleaf Holdings, Inc. (the “Company”) are hereby incorporated by reference into the Registration Statement on Form F-10 (File No. 333-269109) of the Company, as amended or supplemented. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: August 6, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Unaudited Condensed Interim Consolidated Financial Statements as of June 30, 2025 and December 31, 2024 and for the Three and Six Months Ended June 30, 2025 and 2024 and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three and Six Months Ended June 30, 2025 and 2024 99.2 CEO Certification of Interim Filings 99.3 CFO Certification of Interim Filings 99.4 Press Release dated August 6, 2025 EX-99.1 2 q225-exx992xfsandmda.htm EX-99.1 Document Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of June 30, 2025 and December 31, 2024 and For the Three and Six Months Ended June 30, 2025 and 2024 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of June 30, 2025 and December 31, 2024 3 Condensed Interim Consolidated Statements of Operations (Unaudited) for the three and six months ended June 30, 2025 and 2024 5 Condensed Interim Consolidated Statements of Comprehensive Loss (Unaudited) for the three and six months ended June 30, 2025 and 2024 6 Condensed Interim Consolidated Statements of Temporary Equity and Shareholders’ Equity (Unaudited) for the six months ended June 30, 2025 and 2024 7 Condensed Interim Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30, 2025 and 2024 8 Notes to Condensed Interim Consolidated Financial Statements (Unaudited) 10 Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and six months ended June 30, 2025 and 2024 64 Curaleaf Holdings, Inc. Condensed

View on Read The Filing